OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2018
(2)
2025
(1)
2024
(1)
2023
(1)
2021
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Association between type of major duodenal papilla and difficult biliary cannulation at first endoscopic retrograde cholangiopancreatography in adults: a cross-sectional study with bootstrap method
Not available
S-EPMC9932863
|
biostudies-literature
Cite
A randomized controlled trial to assess the efficacy and cost-effectiveness of urinary catheters with silver alloy coating in spinal cord injured patients: trial protocol.
Not available
S-EPMC3735409
|
biostudies-literature
Cite
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE.
Not available
S-EPMC7444639
|
biostudies-literature
Cite
Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry.
Not available
S-EPMC6223517
|
biostudies-literature
Cite
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.
Not available
S-EPMC7943191
|
biostudies-literature
Cite
Cardiac output-guided haemodynamic therapy for patients undergoing major gastrointestinal surgery: OPTIMISE II randomised clinical trial.
Not available
S-EPMC12036648
|
biostudies-literature
Cite
Global hospital-based disease management of acute diverticulitis: a prospective, international cohort study.
Not available
S-EPMC12512976
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets